Pictet Asset Management
TXG icon

Pictet Asset Management’s 10x Genomics TXG Stock Holding History

Pictet Asset Management’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.36M Sell
219,049
-10,178
-4% -$203K ﹤0.01% 801
2025
Q4 		$3.7M Sell
229,227
-8,676
-4% -$131K ﹤0.01% 834
2025
Q3 		$2.7M Buy
237,903
+225,231
+1,777% +$2.94M ﹤0.01% 844
2025
Q2 		$147K Hold
12,672
– – ﹤0.01% 1887
2025
Q1 		$111K Hold
12,672
– – ﹤0.01% 1915
2024
Q4 		$182K Hold
12,672
– – ﹤0.01% 1874
2024
Q3 		$286K Buy
12,672
+2,130
+20% +$44K ﹤0.01% 1634
2024
Q2 		$205K Sell
10,542
-306
-3% -$8.01K ﹤0.01% 1752
2024
Q1 		$407K Buy
10,848
+306
+3% +$13.4K ﹤0.01% 1393
2023
Q4 		$590K Hold
10,542
– – ﹤0.01% 1180
2023
Q3 		$435K Buy
+10,542
New +$548K ﹤0.01% 1296

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Pictet Asset Management's TXG Position: Q1 2026 in Review

Pictet Asset Management reduced its 10x Genomics (TXG) stake by 4.4% in Q1 2026, selling an estimated $203K and leaving 219,049 shares worth $4.36M. The position accounts for ﹤0.01% of the portfolio, ranked #801.

Pictet Asset Management first reported a position in TXG in Q3 2023 and has held it in 11 quarters since. 329 funds tracked by Wall St. Rank hold TXG as of Q1 2026.

  • Pictet Asset Management held 219,049 shares of 10x Genomics worth $4.36M as of Q1 2026.
  • Pictet Asset Management sold 10,178 10x Genomics shares in Q1 2026, an estimated $203K.
  • 10x Genomics made up ﹤0.01% of Pictet Asset Management's portfolio in Q1 2026, its #801 holding.
  • Pictet Asset Management first reported a position in 10x Genomics in Q3 2023 and has held it in 11 quarters since.
  • 329 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2026.

Based on Pictet Asset Management's 13F filing for Q1 2026, filed 22 Apr 2026.